Harvey Investment Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$8.19M |
| 2 |
Core Laboratories
CLB
|
+$3.95M |
| 3 |
Donaldson
DCI
|
+$1.56M |
| 4 |
Fastenal
FAST
|
+$1.12M |
| 5 |
Paychex
PAYX
|
+$432K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$18.9M |
| 2 |
Idexx Laboratories
IDXX
|
+$5.23M |
| 3 |
O'Reilly Automotive
ORLY
|
+$1.5M |
| 4 |
Cenovus Energy
CVE
|
+$706K |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$644K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.97% |
| 2 | Industrials | 18.76% |
| 3 | Consumer Discretionary | 15.22% |
| 4 | Consumer Staples | 13.49% |
| 5 | Financials | 9.64% |
Similar funds
Harvey Investment Company's Q1 2015 Portfolio in Review
As of Q1 2015, Harvey Investment Company held 90 positions worth $420M, down 2.2% from $430M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Harvey Investment Company withdrew a net $14.9M in Q1 2015, closing 5 positions and reducing 31 holdings. Its most notable exit was Allergan Inc, an estimated $18.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Harvey Investment Company opened a new position in Allergan plc worth $8.55M.
- Harvey Investment Company's largest Q1 2015 buy was Allergan plc: 28,740 shares worth $8.55M.
- Harvey Investment Company added most to Core Laboratories in Q1 2015, an estimated $3.95M increase.
- Harvey Investment Company's biggest Q1 2015 reduction was Idexx Laboratories, cutting an estimated $5.23M.
- Harvey Investment Company fully exited Allergan Inc in Q1 2015, selling an estimated $18.9M.
- Harvey Investment Company's ten largest holdings make up 44% of its $420M portfolio in Q1 2015.
- Harvey Investment Company opened 2 new positions and closed 5 in Q1 2015.
- Harvey Investment Company's portfolio value fell 2.2% quarter-over-quarter to $420M.
Based on Harvey Investment Company's 13F filing for Q1 2015, filed 23 Apr 2015.